India-based Lupin Ltd. received U.S. FDA approval to market its Paroxetin extended release tablets, a generic of Apotex Technologies Inc.'s Paxil CR tablets.
The drug is indicated for the treatment of major depressive disorder, panic disorder, social anxiety disorder and premenstrual dysphoric disorder.
Lupin will begin promoting the product soon.